Ambu expands US contracts with single-use endoscopes

All four major purchasing organizations in the US now have products from Ambu's portfolio of single-use endoscopy categories.

BY RITZAU FINANS, TRANSLATED BY NIELSINE NIELSEN

Published: 05.02.21 at 08:47

Ambu has been given contract expansions with two major US purchasing organizations (GPO's) for single-use endoscopes, according to the Danish medtech firm's press statement.

"With these expansions, Ambu is now on contract with all four major GPOs in the US with either a full or partial portfolio of single-use endoscopy categories available for the customers that are served by the GPOs," Ambu states.

Already a subscriber? Log in.

Read the whole article

Get 14 days free access.
No credit card required.

Access all locked articles
Receive our daily newsletters
Access our app

Start a free company trial today

"Real world" patient data documents the long-term effects of ALK vaccines

Data from ALK's React study, which is a retrospective real-world evidence study including more than 92,000 patients with respiratory allergies, have just been published in the journal The Lancet Regional Health – Europe. | Foto: ALK / PR

In the largest study ever of its kind, patient data from the "real world" documents the long-term effects of up to nine years of ALK vaccines. Up until now, it has not been possible to demonstrate these in ordinary clinical studies where the follow-up period is shorter, and the new knowledge could be a turning point in ALK's dialog about prices and subsidies with authorities and payers.